Etoposide and Intervertebral disc degeneration - a phase IV clinical study of FDA data
Summary:
Intervertebral disc degeneration is reported as a side effect among people who take Etoposide (etoposide), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Zometa, and have Anaemia.
The phase IV clinical study analyzes which people have Intervertebral disc degeneration when taking Etoposide. It is created by eHealthMe based on reports of 77,756 people who have side effects when taking Etoposide from the FDA, and is updated regularly.
What is Etoposide?
Etoposide has active ingredients of etoposide. eHealthMe is studying from 77,815 Etoposide users. Check the latest studies of Etoposide.
What is Intervertebral disc degeneration?
Intervertebral disc degeneration (spinal disc degeneration) is found to be associated with 1,312 drugs and 1,499 conditions by eHealthMe. Check the latest studies of Intervertebral disc degeneration.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
77,756 people reported to have side effects when taking Etoposide.
Among them, 12 people (0.02%) have Intervertebral disc degeneration.

Among these 12 people:
How long have people been on Etoposide when they have Intervertebral disc degeneration? *
- < 1 month: 100 %
- 1 - 6 months: 0.0 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
What is the gender of people who have Intervertebral disc degeneration when taking Etoposide? *
- female: 25 %
- male: 75 %
What is the age of people who have Intervertebral disc degeneration when taking Etoposide? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 9.09 %
- 20-29: 0.0 %
- 30-39: 18.18 %
- 40-49: 18.18 %
- 50-59: 0.0 %
- 60+: 54.55 %
What are other drugs people take besides Etoposide? *
- Zometa: 8 people, 66.67%
- Amoxicillin: 7 people, 58.33%
- Acyclovir: 6 people, 50.00%
- Neurontin: 6 people, 50.00%
- Decadron: 6 people, 50.00%
- Oxycontin: 6 people, 50.00%
- Ranitidine: 5 people, 41.67%
- Gabapentin: 5 people, 41.67%
- Fluconazole: 5 people, 41.67%
- Finasteride: 5 people, 41.67%
What are other side effects people have besides Intervertebral disc degeneration? *
- Intervertebral Disc Protrusion (spinal disc protrusion): 8 people, 66.67%
- Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect): 8 people, 66.67%
- Osteonecrosis Of Jaw (death of bone of jaw): 8 people, 66.67%
- Neuropathy Peripheral (surface nerve damage): 8 people, 66.67%
- Hypoaesthesia (reduced sense of touch or sensation): 7 people, 58.33%
- Pain In Jaw: 6 people, 50.00%
- Back Pain: 6 people, 50.00%
- Osteomyelitis (infection of bone): 6 people, 50.00%
- Osteoarthritis (a joint disease caused by cartilage loss in a joint): 6 people, 50.00%
- Loose Tooth: 6 people, 50.00%
What are the existing conditions these people have? *
- Myeloid Leukaemia (a type of cancer in which the bone marrow makes abnormal myeloblasts): 2 people, 16.67%
- Diabetes: 2 people, 16.67%
- Constipation: 2 people, 16.67%
- Anaemia (lack of blood): 2 people, 16.67%
- Osteoporosis (bones weak and more likely to break): 1 person, 8.33%
- Multiple Myeloma (cancer of the plasma cells): 1 person, 8.33%
- Lymphoma (cancer that begins in immune system cells): 1 person, 8.33%
- Diffuse Large B-Cell Lymphoma Refractory (cancer of b cells, a type of white blood cell-relapsed): 1 person, 8.33%
- Ankylosing Spondylitis (type of arthritis affecting the spine): 1 person, 8.33%
* Approximation only. Some reports may have incomplete information.
Do you take Etoposide and have Intervertebral disc degeneration?
- Check whether Intervertebral disc degeneration is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Etoposide:
- Etoposide (77,815 reports)
Intervertebral disc degeneration treatments and more:
- Intervertebral disc degeneration (19,910 reports)
How severe was Intervertebral disc degeneration and when was it recovered:
Expand to all the drugs that have ingredients of etoposide:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Etoposide:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Intervertebral disc degeneration:
- Intervertebral disc degeneration (1,312 drugs)
Browse all the conditions that are associated with Intervertebral disc degeneration:
- Intervertebral disc degeneration (1,499 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on etoposide (the active ingredients of Etoposide) and Etoposide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Eliquis and Drug Abuse for Men aged 50-59 - 15 seconds ago
- Eliquis and Substance Abuse for Men aged 50-59 - 15 seconds ago
- Eliquis and Pcp Abuse for Men aged 50-59 - 15 seconds ago
- Eliquis and Marijuana Abuse for Men aged 50-59 - 15 seconds ago
- Eliquis and Lsd Abuse for Men aged 50-59 - 16 seconds ago
- Eliquis and Illicit Drug Abuse for Men aged 50-59 - 16 seconds ago
- Eliquis and Heroin Abuse for Men aged 50-59 - 16 seconds ago
- Eliquis and Hallucinogen Abuse for Men aged 50-59 - 17 seconds ago
- Eliquis and Cocaine Abuse for Men aged 50-59 - 17 seconds ago
- Eliquis and Narcotic Abuse for Men aged 50-59 - 17 seconds ago